These results are consistent with a prior study that found sulfonylureas and insulin to be linked to a higher incidence of hypoglycemia [17,18]. Additionally, our research showed a lower prevalence among individuals using metformin (n = 69, 18.95%), which has a lower risk of hypoglycemia than sulfonylureas and insulin. This evidence concerns the gene INS and Hypoglycemia.